Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Beyond the semaglutide momentum, a larger wave of patent expiries is set to unf...
Weight management drug to be available from Rs 3,999 per month from April 3, 20...
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Vi...
SSM Health will celebrate a major construction milestone on its new Cardinal Gle...
Agilent Technologies has announced the opening of its Customer Experience Cente...
RYALTRIS is Glenmark’s first innovative product introduced into the US market T...
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to ov...
This follows the company’s signing of a definitive agreement in October 2025 to ...
Under the agreement, Biocytogen’s fully human antibody discovery platform will b...
The IND includes results from completed toxicology, pharmacology, and manufactur...
Healthcare organizations often focus on designing welcoming lobbies and patient-...
The partnership aims to explore a new class of small molecules, called molecular...
Platform to support compliance, training and documentation for over 9,000 lear...
India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Ph...
As pharma companies deal with price wars, increasing regulatory heat and a vola...
Acquisition to include orexin receptor portfolio for sleep and neurological co...
